Jula Inrig - Net Worth and Insider Trading
Jula Inrig Net Worth
The estimated net worth of Jula Inrig is at least $217,128 dollars as of 2024-05-27. Jula Inrig is the Chief Medical Officer of Travere Therapeutics Inc and owns about 35,248 shares of Travere Therapeutics Inc (TVTX) stock worth over $217,128. Details can be seen in Jula Inrig's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jula Inrig has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).
Transaction Summary of Jula Inrig
Jula Inrig Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jula Inrig owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .
Click here to see the complete history of Jula Inrig’s form 4 insider trades.
Insider Ownership Summary of Jula Inrig
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-01-04 | Chief Medical Officer |
Jula Inrig Latest Holdings Summary
Jula Inrig currently owns a total of 1 stock. Jula Inrig owns 35,248 shares of Travere Therapeutics Inc (TVTX) as of January 4, 2024, with a value of $217,128.
Latest Holdings of Jula Inrig
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2024-01-04 | 35,248 | 6.16 | 217,128 |
Holding Weightings of Jula Inrig
Jula Inrig Form 4 Trading Tracker
According to the SEC Form 4 filings, Jula Inrig has made a total of 2 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 2,509 shares on January 4, 2024, which brought Jula Inrig around $23,660.
Insider Trading History of Jula Inrig
- 1
Jula Inrig Trading Performance
Jula Inrig Ownership Network
Jula Inrig Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Jula Inrig is the Chief Medical Officer of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Financial Officer Christopher R. Cline , Senior Vice President & R&D William E. Rote , and VP & Corp Controller and CAO Sandra Calvin .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Jula Inrig made 2 insider transaction in Travere Therapeutics Inc (TVTX) with a net sale of 5,002. Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,306 shares made by Christopher R. Cline , a net sale of 32,591 shares made by Eric M Dube , and a net sale of 9,354 shares made by Elizabeth E Reed .
In summary, during the past 3 months, insiders sold 54 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 54 shares. During the past 18 months, 73,182 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 73,182 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Jula Inrig Mailing Address
Above is the net worth, insider trading, and ownership report for Jula Inrig. You might contact Jula Inrig via mailing address: C/o Travere Therapeutics, Inc., 3611 Valley Centre Drive, Suite 300, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
